-
Mashup Score: 10Gilead Sciences Announces First Quarter 2024 Financial Results - 17 day(s) ago
Gilead Sciences Announces First Quarter 2024 Financial Results
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 8FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six - 2 month(s) ago
FDA Expands Indication for Gilead’s Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 8Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program - 2 month(s) ago
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 15Gilead Sciences Announces Completion of Acquisition of CymaBay - 2 month(s) ago
Gilead Sciences Announces Completion of Acquisition of CymaBay
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 11Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers - 2 month(s) ago
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6Ted Love, MD, Joins Gilead Sciences’ Board of Directors - 3 month(s) ago
Ted Love, MD, Joins Gilead Sciences’ Board of Directors
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 9Gilead Provides Update on Phase 3 EVOKE-01 Study - 4 month(s) ago
Gilead Provides Update on Phase 3 EVOKE-01 Study
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 9Gilead Provides Update on Phase 3 EVOKE-01 Study - 4 month(s) ago
Gilead Provides Update on Phase 3 EVOKE-01 Study
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 9Gilead Provides Update on Phase 3 EVOKE-01 Study - 4 month(s) ago
Gilead Provides Update on Phase 3 EVOKE-01 Study
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 5Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program - 5 month(s) ago
Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program
Source: www.gilead.comCategories: General Medicine News, PayerTweet
#GileadNews: Read the press release to learn more about our financial results from last quarter. https://t.co/KaVPL7z5HE https://t.co/HhRE3Z1VXg